Skip to content

Opening book details…

About this Medicine article

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22 by Trudeau, Maureen Elizabeth; Chapman, Judith-Anne W.; Guo, Baoqing; Clemons, Mark J.; Dent, Rebecca A.; Jong, Roberta A.; Kahn, Harriette J.; Pritchard, Kathleen I.; Han, Lei; O’Brien, Patti; Shepherd, Lois E.; Parissenti, Amadeo M. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Trudeau, Maureen Elizabeth; Chapman, Judith-Anne W.; Guo, Baoqing; Clemons, Mark J.; Dent, Rebecca A.; Jong, Roberta A.; Kahn, Harriette J.; Pritchard, Kathleen I.; Han, Lei; O’Brien, Patti; Shepherd, Lois E.; Parissenti, Amadeo M.
Publisher
Springer; Springer (Biomed Central Ltd.); Springer Science and Business Media Deutschland GmbH; Cham: Springer Internat. Publ.; Springer Science and Business Media LLC (ISSN 2193-1801)
Published
2015
Field
Medicine (Life Sciences)

More by Trudeau, Maureen Elizabeth; Chapman, Judith-Anne W.; Guo, Baoqing; Clemons, Mark J.; Dent, Rebecca A.; Jong, Roberta A.; Kahn, Harriette J.; Pritchard, Kathleen I.; Han, Lei; O’Brien, Patti; Shepherd, Lois E.; Parissenti, Amadeo M.

Browse all works by Trudeau, Maureen Elizabeth; Chapman, Judith-Anne W.; Guo, Baoqing; Clemons, Mark J.; Dent, Rebecca A.; Jong, Roberta A.; Kahn, Harriette J.; Pritchard, Kathleen I.; Han, Lei; O’Brien, Patti; Shepherd, Lois E.; Parissenti, Amadeo M.